Sale!

SLC6A5 Gene Hyperekplexia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SLC6A5 Gene Hyperekplexia NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the SLC6A5 gene responsible for hereditary hyperekplexia, also known as startle disease. This comprehensive test utilizes Next Generation Sequencing technology to detect specific genetic variations that disrupt glycine neurotransmission in the central nervous system. Patients experiencing excessive startle responses, muscle stiffness, and sudden falls should consider this test for accurate diagnosis. The test provides crucial information for treatment planning, family risk assessment, and personalized medical management. Available for $500 USD, this advanced genetic screening offers definitive answers for individuals and families affected by this neurological condition. Early diagnosis through genetic testing can significantly improve quality of life and guide appropriate therapeutic interventions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SLC6A5 Gene Hyperekplexia NGS Genetic DNA Test

Comprehensive Introduction to Hyperekplexia Genetic Testing

The SLC6A5 Gene Hyperekplexia NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for hereditary hyperekplexia. This condition, commonly known as startle disease, is characterized by exaggerated startle responses to unexpected stimuli. Our advanced testing methodology provides definitive answers for patients and families affected by this challenging neurological disorder, enabling accurate diagnosis and targeted treatment approaches.

What Does the SLC6A5 Gene Hyperekplexia Test Measure?

This sophisticated genetic test specifically analyzes the SLC6A5 gene using Next Generation Sequencing technology to detect:

  • Pathogenic variants in the glycine transporter 2 (GlyT2) gene
  • Mutations affecting glycine neurotransmission in the spinal cord and brainstem
  • Genetic alterations that disrupt inhibitory neurotransmission pathways
  • Inherited variations associated with autosomal recessive hyperekplexia
  • Specific nucleotide changes impacting glycine reuptake mechanisms

Who Should Consider SLC6A5 Genetic Testing?

Clinical Indications and Symptoms

This test is recommended for individuals presenting with:

  • Exaggerated startle responses to unexpected auditory or tactile stimuli
  • Generalized muscle stiffness (hypertonia) particularly in infancy
  • Sudden falls without loss of consciousness during startle episodes
  • Family history of similar neurological symptoms
  • Developmental delays associated with startle responses
  • Persistent muscle rigidity that improves during sleep
  • Neonatal hypertonia and exaggerated Moro reflex

Significant Benefits of Genetic Testing

Undergoing SLC6A5 genetic testing provides numerous advantages:

  • Accurate Diagnosis: Confirms hereditary hyperekplexia with molecular precision
  • Personalized Treatment: Guides appropriate medication selection including clonazepam therapy
  • Family Planning: Enables informed reproductive decisions and genetic counseling
  • Prognostic Information: Provides insights into disease progression and management
  • Early Intervention: Facilitates timely therapeutic strategies for improved outcomes
  • Differential Diagnosis: Distinguishes hyperekplexia from other movement disorders

Understanding Your Test Results

Our comprehensive genetic analysis provides clear, actionable results:

  • Positive Result: Indicates presence of pathogenic SLC6A5 mutations confirming hereditary hyperekplexia diagnosis
  • Negative Result: Suggests absence of detectable SLC6A5 mutations, though other genetic causes may be considered
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines inheritance patterns for family risk assessment

All results include detailed interpretation by our board-certified genetic specialists and neurologists, with recommendations for clinical management and follow-up care.

Test Pricing and Availability

Test Component Price (USD)
SLC6A5 Gene Hyperekplexia NGS Genetic DNA Test $700
Discount Price $500

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Department: Genetic Diagnostics

Pre-Test Requirements

To ensure optimal testing outcomes, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to document family pedigree
  • Detailed neurological examination findings
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified collection centers ensures accessible testing nationwide.

Take Control of Your Neurological Health

Don’t let unexplained startle responses and muscle stiffness impact your quality of life. Our SLC6A5 Gene Hyperekplexia NGS Genetic DNA Test provides the definitive answers you need for proper diagnosis and effective management. With our discounted price of $500 USD, advanced genetic testing is more accessible than ever.

Ready to begin your diagnostic journey? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online to schedule your comprehensive genetic evaluation.